2024-09-282024-09-282019-06-010003-9888https://doi.org/10.1136/archdischild-2019-epa.716https://hdl.handle.net/11452/45436eninfo:eu-repo/semantics/closedAccessScience & technologyLife sciences & biomedicinePediatricsSevere neutropenia in ada2 deficiencyMeeting Abstract000541963200716A304A304104Supplement 310.1136/archdischild-2019-epa.716